semaglutide obstructive sleep apnea trial GLP-1 Medications Show Promise as First Drug Therapy for Obstructive sleep apnea — a

Whats Next

Without insurance coverage or a manufacturer savings program, the retail price of these medications at a standard pharmacy exceeds $1,000 per month

For the right patient, these therapies may complement nutrition, exercise, and hormonal balancenot replace themto support sustainable fat loss under a physicians care

Therefore, early diagnosis and treatment are essential to stop the progression of the disease

Consultations for available prescription weight loss medications, including oral and injectable options, when medically appropriate

But remember, retatrutide isnt FDA-approved yet, so Wegovy and Zepbound results remain proven and available options for eligible people